CN104327144B - 3-羟基-5-雄烯-17β羧酸甲酯的制备方法 - Google Patents
3-羟基-5-雄烯-17β羧酸甲酯的制备方法 Download PDFInfo
- Publication number
- CN104327144B CN104327144B CN201410541550.4A CN201410541550A CN104327144B CN 104327144 B CN104327144 B CN 104327144B CN 201410541550 A CN201410541550 A CN 201410541550A CN 104327144 B CN104327144 B CN 104327144B
- Authority
- CN
- China
- Prior art keywords
- androstene
- hydroxyl
- preparation
- acid
- buck
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- -1 carboxylate methyl ester Chemical class 0.000 title claims abstract description 19
- 238000002360 preparation method Methods 0.000 title claims abstract description 18
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 24
- 238000005886 esterification reaction Methods 0.000 claims abstract description 23
- 238000010992 reflux Methods 0.000 claims abstract description 22
- 230000032050 esterification Effects 0.000 claims abstract description 19
- CXHHBNMLPJOKQD-UHFFFAOYSA-M methyl carbonate Chemical compound COC([O-])=O CXHHBNMLPJOKQD-UHFFFAOYSA-M 0.000 claims abstract description 19
- 238000000034 method Methods 0.000 claims abstract description 13
- 238000001816 cooling Methods 0.000 claims abstract description 11
- 239000002253 acid Substances 0.000 claims abstract description 9
- 239000012670 alkaline solution Substances 0.000 claims abstract description 8
- 239000011541 reaction mixture Substances 0.000 claims abstract description 6
- 230000001105 regulatory effect Effects 0.000 claims abstract 2
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 claims description 18
- CDBYLPFSWZWCQE-UHFFFAOYSA-L Sodium Carbonate Chemical compound [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 claims description 14
- 239000000243 solution Substances 0.000 claims description 13
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 claims description 12
- BWHMMNNQKKPAPP-UHFFFAOYSA-L potassium carbonate Chemical compound [K+].[K+].[O-]C([O-])=O BWHMMNNQKKPAPP-UHFFFAOYSA-L 0.000 claims description 10
- 229910000029 sodium carbonate Inorganic materials 0.000 claims description 7
- KWYUFKZDYYNOTN-UHFFFAOYSA-M Potassium hydroxide Chemical compound [OH-].[K+] KWYUFKZDYYNOTN-UHFFFAOYSA-M 0.000 claims description 6
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 claims description 4
- NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 claims description 4
- UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical compound [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 claims description 4
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 claims description 4
- 229910052784 alkaline earth metal Inorganic materials 0.000 claims description 4
- 150000001342 alkaline earth metals Chemical class 0.000 claims description 4
- 229910052728 basic metal Inorganic materials 0.000 claims description 4
- 150000003818 basic metals Chemical class 0.000 claims description 4
- 235000015320 potassium carbonate Nutrition 0.000 claims description 4
- 229910000027 potassium carbonate Inorganic materials 0.000 claims description 3
- 235000011181 potassium carbonates Nutrition 0.000 claims description 3
- 238000010792 warming Methods 0.000 claims description 3
- BVKZGUZCCUSVTD-UHFFFAOYSA-L Carbonate Chemical compound [O-]C([O-])=O BVKZGUZCCUSVTD-UHFFFAOYSA-L 0.000 claims description 2
- 229960000583 acetic acid Drugs 0.000 claims description 2
- 229910000147 aluminium phosphate Inorganic materials 0.000 claims description 2
- 239000007864 aqueous solution Substances 0.000 claims description 2
- 239000012362 glacial acetic acid Substances 0.000 claims description 2
- 235000015497 potassium bicarbonate Nutrition 0.000 claims description 2
- 229910000028 potassium bicarbonate Inorganic materials 0.000 claims description 2
- 239000011736 potassium bicarbonate Substances 0.000 claims description 2
- TYJJADVDDVDEDZ-UHFFFAOYSA-M potassium hydrogencarbonate Chemical compound [K+].OC([O-])=O TYJJADVDDVDEDZ-UHFFFAOYSA-M 0.000 claims description 2
- 229910000030 sodium bicarbonate Inorganic materials 0.000 claims description 2
- 235000017557 sodium bicarbonate Nutrition 0.000 claims description 2
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 abstract description 15
- 230000007613 environmental effect Effects 0.000 abstract description 4
- JZMJDSHXVKJFKW-UHFFFAOYSA-M methyl sulfate(1-) Chemical compound COS([O-])(=O)=O JZMJDSHXVKJFKW-UHFFFAOYSA-M 0.000 abstract description 4
- 231100000419 toxicity Toxicity 0.000 abstract description 3
- 230000001988 toxicity Effects 0.000 abstract description 3
- 230000000630 rising effect Effects 0.000 abstract description 2
- 231100000004 severe toxicity Toxicity 0.000 abstract description 2
- 238000006243 chemical reaction Methods 0.000 description 13
- 238000005070 sampling Methods 0.000 description 8
- 238000003756 stirring Methods 0.000 description 8
- 210000003298 dental enamel Anatomy 0.000 description 4
- 238000004519 manufacturing process Methods 0.000 description 4
- 239000003814 drug Substances 0.000 description 3
- DBEPLOCGEIEOCV-WSBQPABSSA-N finasteride Chemical compound N([C@@H]1CC2)C(=O)C=C[C@]1(C)[C@@H]1[C@@H]2[C@@H]2CC[C@H](C(=O)NC(C)(C)C)[C@@]2(C)CC1 DBEPLOCGEIEOCV-WSBQPABSSA-N 0.000 description 3
- 229960004039 finasteride Drugs 0.000 description 3
- 230000015572 biosynthetic process Effects 0.000 description 2
- 150000001875 compounds Chemical class 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- 230000004048 modification Effects 0.000 description 2
- 238000012986 modification Methods 0.000 description 2
- 238000007254 oxidation reaction Methods 0.000 description 2
- 239000002994 raw material Substances 0.000 description 2
- 238000003786 synthesis reaction Methods 0.000 description 2
- 229940113178 5 Alpha reductase inhibitor Drugs 0.000 description 1
- 239000002677 5-alpha reductase inhibitor Substances 0.000 description 1
- 206010004446 Benign prostatic hyperplasia Diseases 0.000 description 1
- VAPSMQAHNAZRKC-PQWRYPMOSA-N Epristeride Chemical compound C1C=C2C=C(C(O)=O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H](C(=O)NC(C)(C)C)[C@@]1(C)CC2 VAPSMQAHNAZRKC-PQWRYPMOSA-N 0.000 description 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 1
- 239000003377 acid catalyst Substances 0.000 description 1
- 150000001263 acyl chlorides Chemical class 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 150000001732 carboxylic acid derivatives Chemical class 0.000 description 1
- 125000001309 chloro group Chemical group Cl* 0.000 description 1
- 238000005260 corrosion Methods 0.000 description 1
- 230000007797 corrosion Effects 0.000 description 1
- 229950009537 epristeride Drugs 0.000 description 1
- 239000012065 filter cake Substances 0.000 description 1
- 125000002887 hydroxy group Chemical group [H]O* 0.000 description 1
- 231100000053 low toxicity Toxicity 0.000 description 1
- 230000007935 neutral effect Effects 0.000 description 1
- 229910052700 potassium Inorganic materials 0.000 description 1
- 239000011591 potassium Substances 0.000 description 1
- 239000000047 product Substances 0.000 description 1
- 239000000376 reactant Substances 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 239000002904 solvent Substances 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 238000010189 synthetic method Methods 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J3/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by one carbon atom
- C07J3/005—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by one carbon atom the carbon atom being part of a carboxylic function
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Abstract
Description
Claims (9)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201410541550.4A CN104327144B (zh) | 2014-10-14 | 2014-10-14 | 3-羟基-5-雄烯-17β羧酸甲酯的制备方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201410541550.4A CN104327144B (zh) | 2014-10-14 | 2014-10-14 | 3-羟基-5-雄烯-17β羧酸甲酯的制备方法 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN104327144A CN104327144A (zh) | 2015-02-04 |
CN104327144B true CN104327144B (zh) | 2016-03-09 |
Family
ID=52401959
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201410541550.4A Active CN104327144B (zh) | 2014-10-14 | 2014-10-14 | 3-羟基-5-雄烯-17β羧酸甲酯的制备方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN104327144B (zh) |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CH227069A (de) * | 1937-03-17 | 1943-05-15 | Organon Nv | Verfahren zur Herstellung einer Cyclopentano-dimethyl-polyhydrophenanthren-carbonsäure. |
GB644526A (en) * | 1947-05-14 | 1950-10-11 | Ciba Ltd | Manufacture of steroid-17-carboxylic acids |
CN102675393B (zh) * | 2012-04-09 | 2014-05-07 | 浙江仙琚制药股份有限公司 | 制备19-去甲-4-雄烯二酮的方法 |
-
2014
- 2014-10-14 CN CN201410541550.4A patent/CN104327144B/zh active Active
Also Published As
Publication number | Publication date |
---|---|
CN104327144A (zh) | 2015-02-04 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN104230777B (zh) | 一种奥拉西坦的合成方法 | |
CN104045637B (zh) | 一种阿哌沙班的制备方法 | |
CN105693554B (zh) | 丙氨酸衍生物的制备方法 | |
CN103724279B (zh) | 一步成环制备2-甲基-4-氨基-5-氨基甲基嘧啶的便捷合成方法 | |
CN106496038A (zh) | 一种高选择性的3‑甲基‑2‑硝基苯甲酸的制备方法 | |
CN101531654B (zh) | 一种卢帕他定的制备方法 | |
CN111087328A (zh) | 脂肪醇磺基琥珀酸单酯二钠盐的制备方法 | |
CN110003203A (zh) | 一种合成2-乙酰基-1,10-菲啰啉(3)的方法 | |
CN104496825B (zh) | 2-氟乙胺盐酸盐的制备方法 | |
CN104327144B (zh) | 3-羟基-5-雄烯-17β羧酸甲酯的制备方法 | |
CN103420833A (zh) | 一种对甲苯磺酸催化的丙二酸二甲酯合成方法 | |
CN102167667B (zh) | 一种季戊四醇四苯甲酸酯的合成方法 | |
CN105585539A (zh) | 一锅法合成头孢他啶侧链酸乙酯的方法 | |
CN103145605A (zh) | 一种1-乙酰基-卤代吲哚基-3-乙酸酯的合成方法 | |
CN104557902B (zh) | 一种制备噻苯咪唑的方法 | |
CN107417516A (zh) | 一种回收利用一锅法制备d‑(+)‑2‑氯丙酰氯的蒸馏残液的方法 | |
CN110128298B (zh) | 一种沙库巴曲中间体的合成方法 | |
CN103360433B (zh) | 一种一锅法合成三氯蔗糖-6-乙酸酯的方法 | |
CN106986809A (zh) | 一种5‑溴‑6‑氯‑3‑吲哚辛酯的合成方法 | |
CN101463033A (zh) | 一种二羟丙茶碱的合成方法 | |
CN105175250B (zh) | 一种合成环丙贝特的新方法 | |
CN110903211A (zh) | L-茶氨酸的制备方法 | |
CN104557604B (zh) | 5‑乙酰基水杨酰胺的合成方法 | |
CN106543108A (zh) | 一种3‑丙基‑环氧乙烷‑2‑羰基环丙酰胺的工业化制备方法 | |
CN112159347B (zh) | 吡考他胺的制备方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
CB02 | Change of applicant information |
Address after: 422900 Xinshao Economic Development Zone, Shaoyang Province, Xing Road, economic development zone, Hunan Applicant after: HUNAN KEREY PHARMACEUTICAL Co.,Ltd. Address before: 422900 Xinshao Economic Development Zone, Shaoyang Province, Xing Road, economic development zone, Hunan Applicant before: HUNAN KEREY BIOTECHNOLOGY Co.,Ltd. |
|
COR | Change of bibliographic data | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
PE01 | Entry into force of the registration of the contract for pledge of patent right |
Denomination of invention: Preparation of methyl 3-hydroxy-5-androstene-17 b carboxylic acid Effective date of registration: 20200928 Granted publication date: 20160309 Pledgee: China Co. truction Bank Corp Xinshao branch Pledgor: HUNAN KEREY PHARMACEUTICAL Co.,Ltd. Registration number: Y2020980006554 |
|
PE01 | Entry into force of the registration of the contract for pledge of patent right | ||
PC01 | Cancellation of the registration of the contract for pledge of patent right |
Date of cancellation: 20230131 Granted publication date: 20160309 Pledgee: China Co. truction Bank Corp Xinshao branch Pledgor: HUNAN KEREY PHARMACEUTICAL Co.,Ltd. Registration number: Y2020980006554 |
|
PC01 | Cancellation of the registration of the contract for pledge of patent right | ||
PE01 | Entry into force of the registration of the contract for pledge of patent right |
Denomination of invention: 3-Hydroxy-5-androsten-17 b Preparation method of methyl carboxylate Granted publication date: 20160309 Pledgee: Industrial and Commercial Bank of China Limited Shaoyang Beita Branch Pledgor: HUNAN KEREY PHARMACEUTICAL Co.,Ltd. Registration number: Y2024980006163 |
|
PE01 | Entry into force of the registration of the contract for pledge of patent right |